NASDAQ: ARVN - Arvinas, Inc.

Rentabilidade por seis meses: -66.63%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Arvinas, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Arvinas, Inc.

Arvinas, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается открытием, разработкой и коммерциализацией препаратов для разложения белков, вызывающих заболевания.

mais detalhes
Ведущие продукты компании включают АРВ-110, химеры, нацеленные на протеолиз (PROTAC), который находится в фазе I клинических испытаний, направленных на белок рецептора андрогенов (AR) для лечения мужчин с метастатическим устойчивым к кастрации раком простаты; и ARV-471, PROTAC, нацеленный на белок рецептора эстрогена, для лечения пациентов с метастатическим ER-положительным ER2-отрицательным раком молочной железы. Он также разрабатывает другие PROTAC для деградации AR и других клинически значимых точечных мутаций AR; и различные другие продукты для лечения нейродегенеративных заболеваний, включая таупатии. Компания сотрудничает с Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd. и Bayer AG. Компания Arvinas, Inc. была основана в 2015 году и находится в Нью-Хейвене, штат Коннектикут.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2018-09-27
ISIN US04335A1051
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.arvinas.com
Цена ао 8.13
Alteração de preço por dia: 0% (8.13)
Alteração de preço por semana: -6.55% (8.7)
Alteração de preço por mês: -51.46% (16.75)
Alteração de preço em 3 meses: -56.59% (18.73)
Mudança de preço em seis meses: -66.63% (24.36)
Mudança de preço por ano: -80.33% (41.33)
Mudança de preço em 3 anos: -87.51% (65.1)
Mudança de preço em 5 anos: -83.98% (50.75)
Mudança de preço desde o início do ano: -57.21% (19)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 5.19 3
P/BV 2.43 6
P/E 0 0
EV/EBITDA -5.09 0
Total: 4.75

Eficiência

Nome Significado Nota
ROA, % -16.6 0
ROE, % -32.56 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0364 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 1108.26 10
Rentabilidade Ebitda, % 100.32 10
Rentabilidade EPS, % -0.4913 0
Total: 7.8
Mais detalhes

Instituições Volume Compartilhar, %
EcoR1 Capital, LLC 6726491 9.88
Blackrock Inc. 5354864 7.87
Vanguard Group Inc 4851390 7.13
RTW Investments LP 4213483 6.19
Price (T.Rowe) Associates Inc 3832123 5.63
Avidity Partners Management, LP 2985117 4.38
Bellevue Group AG 2507731 3.68
Citadel Advisors Llc 2439981 3.58
FMR, LLC 2244019 3.3
JP Morgan Chase & Company 2172829 3.19

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
SPDR S&P Pharmaceuticals ETF 2.61231 29.8 1.29889
Direxion Daily Pharmaceutical & Medical Bull 3X Shares 2.13134 86.72 1.2989
Virtus LifeSci Biotech Clinical Trials ETF 0.76773 63.04 0.33
Range Cancer Therapeutics ETF 0.76388 47.24 0.11955
iShares U.S. Pharmaceuticals ETF 0.63255 6.09 1.97922
First Trust Nasdaq Pharmaceuticals ETF 0.26181 18.37 2.19901
ProShares UltraShort Nasdaq Biotechnology 0.24 -40.36 1.76
Future Tech ETF 0.17013 426.34 0.8416
Principal Healthcare Innovators ETF 0.17013 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.16864 28.58 0.8565
iShares Russell 2000 Growth ETF 0.12173 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.12 23.05 0.60264
Nuveen ESG Small-Cap ETF 0.11798 13.91 1.41019
ProShares Ultra Nasdaq Biotechnology 0.11355 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.08323 24.75 1.59225
Vanguard Russell 2000 ETF 0.06 17.16 1.48801
iShares ESG Aware MSCI USA Small-Cap ETF 0.04923 18.09 1.49366
WisdomTree U.S. SmallCap Fund 0.04788 15.03 1.80258
Schwab U.S. Small-Cap ETF 0.04625 17.47 1.51433
ProShares UltraPro Russell2000 0.03557 89.82 1.47873
iShares Morningstar Small-Cap Growth ETF 0.03139 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.03139 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.02788 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.02788 391.25 1.60498
iShares Morningstar Small-Cap Value ETF 0.02334 201.65 2.50476
iShares Morningstar Small Cap Value ETF 0.02334 26.7 2.50476
Fidelity MSCI Health Care Index ETF 0.01808 3 1.46057
Avantis Responsible U.S. Equity ETF 0.0117 26.78 1.45257
Humankind US Stock ETF 0.0108 18.81 1.99919
Dimensional U.S. Core Equity 2 ETF 0.01 30.76 1.47098
ProShares Hedge Replication ETF 0.0098 5.92 1.47892
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.00885 17.58 1.75869
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00602 21.94 1.69572
Avantis U.S. Equity ETF 0.00597 23.04 1.59151
SPDR Portfolio MSCI Global Stock Market ETF 0.00375 17.99 2.19607
Dimensional US Core Equity Market ETF 0.00352 30.98 1.40618
Schwab U.S. Broad Market ETF 0.00316 24.86 1.43354
Dimensional U.S. Equity ETF 0.00263 31.53 1.3557
iShares Russell 3000 ETF 0.00252 24.83 1.43482
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.22781.4



Supervisor Cargo Pagamento Ano de nascimento
Dr. John G. Houston Ph.D. Chairperson, CEO & President 1.08M 1960 (65 anos)
Dr. Ian Taylor Ph.D. President of Research & Development and Chairman of Scientific Advisory Board 692k 1963 (62 ano)
Mr. Steve Weiss Senior VP & Chief Human Resources Officer N/A 1970 (55 anos)
Mr. Jeff Boyle Vice President of Investor Relations N/A
Dr. Randy Teel Ph.D. Chief Business Officer N/A 1980 (45 anos)
Dr. John A. Grosso Ph.D. Senior Vice President of R&D Technical Operations N/A 1957 (68 anos)
Mr. David K. Loomis M.B.A. VP, Chief Accounting Officer & Corporate Controller N/A 1974 (51 ano)
Ms. Angela M. Cacace Ph.D. Chief Scientific Officer N/A 1968 (57 anos)
Mr. Jared M. Freedberg J.D. General Counsel & Corporate Secretary N/A 1969 (56 anos)
Mr. Andrew R. Saik CFO & Treasurer 1969 (56 anos)

Endereço: United States, New Haven, CT , 5 Science Park - abrir no Google Maps, abrir mapas Yandex
Site: http://www.arvinas.com